Tucatinib + Mao Inhibitors Interaction
Majorinteraction on record
Description
Concomitant use increases tucatinib plasma concentrations, which may increase the risk of TUKYSA toxicity.
Mechanism
CYP2C8 inhibition
Source: NLP:tucatinib
Concomitant use increases tucatinib plasma concentrations, which may increase the risk of TUKYSA toxicity.
CYP2C8 inhibition
Source: NLP:tucatinib